Although with the limit of the small number of patients, the higher uptake of 18F-DOPA in high grade tumors than in low-grade lesions may reflect additional factors other than the expression of amino-acid transporters, namely tumor and aggressiveness (e.g., ki-67 proliferation and tumor grade) and correlation with outcome. Here, MKI67 is linked to neoplasm.